Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by

Amarsanaa Jazag1, Hideaki Ijichi, Fumihiko Kanai

  • 1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Oncogene
|December 14, 2004
PubMed

Insights

Smad4 gene knockdown in pancreatic cancer cells inhibits transforming growth factor-beta (TGF-beta) signaling. This study identified novel TGF-beta target genes and revealed Smad4

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The transforming growth factor-beta (TGF-beta)-Smad signaling pathway is crucial for epithelial cell growth inhibition and tumor suppression.
  • Smad4 gene mutations or deletions are prevalent in approximately 50% of human pancreatic cancers, highlighting its significance in tumorigenesis.

Purpose of the Study:

  • To establish Smad4 knockdown (S4KD) pancreatic cancer cell lines using stable RNA interference (RNAi) to investigate TGF-beta-Smad signaling.
  • To identify novel downstream target genes of TGF-beta signaling regulated by Smad4 status using cDNA microarray analysis.

Main Methods:

  • Generation of S4KD pancreatic cancer cell lines via stable RNA interference (RNAi) to reduce Smad4 protein expression.
  • Stimulation of S4KD and control cells with TGF-beta, followed by cDNA microarray analysis of 3756 genes.
  • Validation of microarray results using quantitative RT-PCR (qRT-PCR).

Main Results:

  • TGF-beta-Smad signaling was markedly inhibited in S4KD cell lines.
  • Microarray analysis identified 187 S4KD-specific and 155 control-specific genes regulated by TGF-beta stimulation.
  • Differential regulation of genes involved in cell proliferation, adhesion, and motility was observed between S4KD and control cells.
  • TGF-beta-induced cell migration was inhibited in S4KD cells, potentially linked to altered integrin beta7 regulation.
  • 246 novel TGF-beta downstream genes were identified.

Conclusions:

  • Stable RNAi is an effective tool for analyzing endogenous gene function.
  • Smad4 status significantly influences TGF-beta signaling pathways, impacting cell proliferation, adhesion, and motility.
  • The findings provide insights into the role of Smad4 in pancreatic cancer and identify potential therapeutic targets.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...